<i>TP53</i> Mutation Is a Prognostic Factor in Lower Grade Glioma and May Influence Chemotherapy Efficacy.

Cancers (Basel) · 2021 · PMC8582451 · PMID 34771529

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

showed a trendp = 0.056so close (0.05 < p ≤ 0.1)

In multivariate analysis, other TP53 mutations only showed a trend of decreased PFS ( p = 0.056); however, codon 273 mutation remained a significant prognostic factor for oligodendroglioma OS in multivariate analysis (HR (95% CI): 9.05 (2.39–34.31), p = 0.001).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.